Wang, J., Wu, H., Sun, J., Li, X., Shu, Y., Wu, X., . . . Li, X. Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: A single-arm, open-label, phase II trial. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Jian, et al. Camrelizumab Plus Gemcitabine and Oxaliplatin (GEMOX) in Patients with Advanced Biliary Tract Cancer: A Single-arm, Open-label, Phase II Trial. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Jian, et al. Camrelizumab Plus Gemcitabine and Oxaliplatin (GEMOX) in Patients with Advanced Biliary Tract Cancer: A Single-arm, Open-label, Phase II Trial. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.